Study Objective: To evaluate the steady-state pharmacokinetic and pharmacodynamic parameters of piperacillin in morbidly obese, surgical intensive care patients.
Design: Open-label single-center prospective study.
Setting: Level I trauma center and university-affiliated teaching institution.